全文获取类型
收费全文 | 178802篇 |
免费 | 11472篇 |
国内免费 | 707篇 |
专业分类
耳鼻咽喉 | 2503篇 |
儿科学 | 4876篇 |
妇产科学 | 3435篇 |
基础医学 | 23182篇 |
口腔科学 | 3546篇 |
临床医学 | 17511篇 |
内科学 | 38293篇 |
皮肤病学 | 2801篇 |
神经病学 | 17951篇 |
特种医学 | 6213篇 |
外国民族医学 | 13篇 |
外科学 | 26475篇 |
综合类 | 2301篇 |
现状与发展 | 3篇 |
一般理论 | 201篇 |
预防医学 | 13296篇 |
眼科学 | 4781篇 |
药学 | 11512篇 |
中国医学 | 203篇 |
肿瘤学 | 11885篇 |
出版年
2023年 | 697篇 |
2022年 | 1223篇 |
2021年 | 2862篇 |
2020年 | 1761篇 |
2019年 | 2885篇 |
2018年 | 3396篇 |
2017年 | 2453篇 |
2016年 | 2859篇 |
2015年 | 3454篇 |
2014年 | 5107篇 |
2013年 | 7877篇 |
2012年 | 11387篇 |
2011年 | 12247篇 |
2010年 | 6835篇 |
2009年 | 6304篇 |
2008年 | 11530篇 |
2007年 | 12296篇 |
2006年 | 11797篇 |
2005年 | 12159篇 |
2004年 | 11551篇 |
2003年 | 11025篇 |
2002年 | 10635篇 |
2001年 | 1482篇 |
2000年 | 1123篇 |
1999年 | 1590篇 |
1998年 | 2329篇 |
1997年 | 2020篇 |
1996年 | 1702篇 |
1995年 | 1581篇 |
1994年 | 1423篇 |
1993年 | 1354篇 |
1992年 | 1040篇 |
1991年 | 953篇 |
1990年 | 834篇 |
1989年 | 816篇 |
1988年 | 837篇 |
1987年 | 718篇 |
1986年 | 835篇 |
1985年 | 916篇 |
1984年 | 1221篇 |
1983年 | 1173篇 |
1982年 | 1639篇 |
1981年 | 1512篇 |
1980年 | 1416篇 |
1979年 | 785篇 |
1978年 | 906篇 |
1977年 | 800篇 |
1976年 | 707篇 |
1975年 | 566篇 |
1974年 | 593篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
971.
972.
973.
Adams Brian J. Turner Blair Wang Xinzi Marro Rachel Miller Elizabeth Phillips Gregory Coulter Robert W. S. 《Prevention science》2021,22(2):227-236
Prevention Science - Intimate partner violence (IPV) impacts sexual minority adolescents at rates equal to or greater than the rate it impacts heterosexual adolescents. We investigated whether... 相似文献
974.
Fan Jonathan K. Macpherson Robert A. Smith Peter M. Harris M. Anne Gignac Monique A. M. McLeod Christopher B. 《Journal of occupational rehabilitation》2021,31(2):339-349
Journal of Occupational Rehabilitation - Purpose This study aimed to understand age differences in wage-replacement duration by focusing on variations in the relationship across different periods... 相似文献
975.
Wong Jasin Kallish Natasha Crown Deborah Capraro Pamela Trierweiler Robert Wafford Q. Eileen Tiema-Benson Laurine Hassan Shahzeb Engel Edeth Tamayo Christina Heinemann Allen W. 《Journal of occupational rehabilitation》2021,31(3):474-490
Journal of Occupational Rehabilitation - Purpose We aimed to identify job accommodations that help persons with physical disabilities maintain or return to work and explore the barriers and... 相似文献
976.
Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help? 总被引:10,自引:6,他引:4 下载免费PDF全文
977.
978.
979.
Chris A. Anthony Marcin K. Wasko Gail E. Pashos Robert L. Barrack Ryan M. Nunley John C. Clohisy 《The Journal of arthroplasty》2021,36(7):2518-2522
BackgroundComplications and patient-reported outcomes (PROs) of total hip arthroplasty (THA) in patients with Legg-Calve-Perthes disease (LCPD) have demonstrated variable results. The purpose of this study was to use a validated grading scheme to analyze complications associated with THA in patients with residual LCPD deformities. Second, we report PROs and intermediate-term survivorship in this patient population.MethodsA retrospective, single-center review was performed on 61 hips in 61 patients who underwent THA for residual Perthes disease. Average patient age was 42 years and 26% of hips had previous surgery. Complications were determined and categorized using a validated grading scheme that included five grades based on the treatment required to manage the complication and on persistent disability. PROs were compared from preoperative to most recent follow-up time points.ResultsMajor complications (grade III) occurred in three patients (5%) which each required a second surgical intervention. The most common minor grade I or II complications (11.5%) were asymptomatic heterotopic ossification (3.3%). Patients were lengthened on the surgical side an average of 1.4 cm with no nerve palsies. All patient PROs improved from preoperative to postoperative time points with the modified Harris Hip Score improving from 46.9 preoperatively to 85.4 postoperatively (P < .01). Patients free from revision for any reason at final follow-up (5.6 years; range 2-13 years) was 98.4% with one patient needing a revision of their femoral component.ConclusionsTHA for the sequelae of the LCPD has an acceptable complication rate and provides excellent patient reported outcomes at mid-term follow-up. 相似文献
980.
Isabel M. A. Brüggenwirth Maureen J. M. Werner René Adam Wojciech G. Polak Vincent Karam Michael A. Heneghan Arianeb Mehrabi Jürgen L. Klempnauer Andreas Paul Darius F. Mirza Johann Pratschke Mauro Salizzoni Daniel Cherqui Michael Allison Olivier Soubrane Steven J. Staffa David Zurakowski Robert J. Porte Vincent E. de Meijer all the other contributing centers the European Liver Intestine Transplant Association 《Transplant international》2021,34(10):1928-1937
High-risk combinations of recipient and graft characteristics are poorly defined for liver retransplantation (reLT) in the current era. We aimed to develop a risk model for survival after reLT using data from the European Liver Transplantation Registry, followed by internal and external validation. From 2006 to 2016, 85 067 liver transplants were recorded, including 5581 reLTs (6.6%). The final model included seven predictors of graft survival: recipient age, model for end-stage liver disease score, indication for reLT, recipient hospitalization, time between primary liver transplantation and reLT, donor age, and cold ischemia time. By assigning points to each variable in proportion to their hazard ratio, a simplified risk score was created ranging 0–10. Low-risk (0–3), medium-risk (4–5), and high-risk (6–10) groups were identified with significantly different 5-year survival rates ranging 56.9% (95% CI 52.8–60.7%), 46.3% (95% CI 41.1–51.4%), and 32.1% (95% CI 23.5–41.0%), respectively (P < 0.001). External validation showed that the expected survival rates were closely aligned with the observed mortality probabilities. The Retransplantation Risk Score identifies high-risk combinations of recipient- and graft-related factors prognostic for long-term graft survival after reLT. This tool may serve as a guidance for clinical decision-making on liver acceptance for reLT. 相似文献